sorafenib has been researched along with Diabetic Retinopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dave, V; Gupta, C; Sharma, R; Sur, S | 1 |
| Abbate, I; Apicella, I; Bucolo, C; D'Agata, V; De Falco, S; Giuliano, F; La Rosa, LR; Maugeri, G; Mazzone, MG; Platania, CBM; Santonocito, M; Solfato, E; Tarallo, V; Viola, S; Zappulla, C | 1 |
2 other study(ies) available for sorafenib and Diabetic Retinopathy
| Article | Year |
|---|---|
Folic acid modified gold nanoparticle for targeted delivery of Sorafenib tosylate towards the treatment of diabetic retinopathy.
Topics: Diabetes Mellitus; Diabetic Retinopathy; Drug Delivery Systems; Folic Acid; Gold; Humans; Metal Nanoparticles; Sorafenib | 2020 |
Assessment of a New Nanostructured Microemulsion System for Ocular Delivery of Sorafenib to Posterior Segment of the Eye.
Topics: Administration, Ophthalmic; Animals; Choroidal Neovascularization; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Emulsions; Female; Male; Mice; Mice, Inbred C57BL; Nanostructures; Protein Kinase Inhibitors; Rabbits; Rats; Rats, Sprague-Dawley; Retinal Diseases; Retinal Neovascularization; Sorafenib | 2021 |